BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19998821)

  • 1. [Polygenetic disturbance in the front line mucosa defense].
    Söderholm JD; Pettersson S
    Lakartidningen; 2009 Nov 4-12; 106(45):2974, 2976-8. PubMed ID: 19998821
    [No Abstract]   [Full Text] [Related]  

  • 2. Etiology and pathogenesis of inflammatory bowel disease.
    Schmidt C; Stallmach A
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):127-45. PubMed ID: 15990703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of genetic, environmental and immune factors in the pathogenesis of inflammatory bowel diseases.
    Chowers Y
    Isr Med Assoc J; 2002 Oct; 4(10):815-7. PubMed ID: 12389349
    [No Abstract]   [Full Text] [Related]  

  • 4. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis.
    Agius LM
    J Theor Biol; 2004 Mar; 227(2):219-28. PubMed ID: 14990386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetics and immunopathogenesis of inflammatory bowel disease.
    Cho JH
    Nat Rev Immunol; 2008 Jun; 8(6):458-66. PubMed ID: 18500230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of IBD: genetic versus environmental influences on the etiology of disease.
    Mack DR
    J Pediatr Gastroenterol Nutr; 1992 Jan; 14(1):117. PubMed ID: 1573502
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms and efficacy of immunobiologic therapies for inflammatory bowel diseases.
    Ghosh N; Chaki R; Mandal V; Lin GD; Mandal SC
    Int Rev Immunol; 2010; 29(1):4-37. PubMed ID: 20100080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent understanding of IBD pathogenesis: implications for future therapies.
    Kucharzik T; Maaser C; Lügering A; Kagnoff M; Mayer L; Targan S; Domschke W
    Inflamm Bowel Dis; 2006 Nov; 12(11):1068-83. PubMed ID: 17075348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell apoptosis and inflammatory bowel disease.
    Peppelenbosch MP; van Deventer SJ
    Gut; 2004 Nov; 53(11):1556-8. PubMed ID: 15479669
    [No Abstract]   [Full Text] [Related]  

  • 10. [Etiology and pathogenesis of Crohn disease and ulcerative colitis].
    Knoflach P
    Wien Klin Wochenschr; 1986 Nov; 98(22):754-8. PubMed ID: 3811368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploitation of the whole gut lavage technique for in vivo assessment of intestinal immunity and inflammation in inflammatory bowel disease.
    Ferguson A; Choudari CP; Mwantembe O; Handy L
    Adv Exp Med Biol; 1995; 371B():1257-60. PubMed ID: 7502795
    [No Abstract]   [Full Text] [Related]  

  • 12. Inflammatory bowel disease and innate immune response genes: the challenge of complex polygenic disorders for the clinical geneticist.
    Haigh B
    Clin Genet; 2006 Apr; 69(4):315-8. PubMed ID: 16630164
    [No Abstract]   [Full Text] [Related]  

  • 13. The immunology of inflammatory bowel disease.
    MacKechnie HL
    Henry Ford Hosp Med J; 1982; 30(1):25-32. PubMed ID: 6123493
    [No Abstract]   [Full Text] [Related]  

  • 14. The IL-10 gene is not involved in the predisposition to inflammatory bowel disease.
    Klein W; Tromm A; Griga T; Fricke H; Folwaczny C; Hocke M; Eitner K; Marx M; Runte M; Epplen JT
    Electrophoresis; 2000 Nov; 21(17):3578-82. PubMed ID: 11271474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inflammatory bowel diseases: an immunological approach].
    Sepúlveda SE; Beltrán CJ; Peralta A; Rivas P; Rojas N; Figueroa C; Quera R; Hermoso MA
    Rev Med Chil; 2008 Mar; 136(3):367-75. PubMed ID: 18575665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SAMP1/Yit mouse: another step closer to modeling human inflammatory bowel disease.
    Strober W; Nakamura K; Kitani A
    J Clin Invest; 2001 Mar; 107(6):667-70. PubMed ID: 11254665
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chronic inflammatory bowel disease--pathogenic concepts and therapeutic perspectives].
    Madsen JR
    Ugeskr Laeger; 2000 Mar; 162(10):1361-6. PubMed ID: 10745672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA4/CT60 polymorphism is not relevant in susceptibility to autoimmune inflammatory intestinal disorders.
    Rueda B; Zhernakova A; López-Nevot MA; Gomez-Garcia M; Ortega E; Piñero A; Correro F; Brieva JA; Nieto A; Koeleman BP; Martín J
    Hum Immunol; 2005 Mar; 66(3):321-5. PubMed ID: 15784471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
    Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrigenomics and inflammatory bowel diseases.
    Ferguson LR
    Expert Rev Clin Immunol; 2010 Jul; 6(4):573-83. PubMed ID: 20594131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.